Study Finds People With Psoriatic Arthritis Have Increased Risk for LupusA recent study published in The Journal of Rheumatology has explored the potential link between psoriatic arthritis (PsA) and lupus.1PsA often occurs alongside psoriasis, an inflammatory skin condition. However, in... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Vaccine And LupusThe COVID-19 pandemic has led to uncertainty for many. Fortunately, researchers have been working hard to learn more about the virus, ways to treat it, and potential vaccines. However, with... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Study: Black People with Lupus May Have Higher Risk for Stroke and Heart DiseaseNew information sheds more light on the relationship between race and lupus and invites Black people with lupus to talk to their doctors about their risk of heart disease and... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
COVID-19 and Flu: Similarities, Differences, and How to Protect YourselfAs the coronavirus and flu season collide, this upcoming winter will be like none the world has ever seen. Here in the United States, it is important to know how... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Benlysta® (Belimumab) for People with Lupus NephritisThe U.S. Food and Drug Administration (FDA) has approved the use of the drug Benlysta® (belimumab) in people with lupus nephritis. This makes belimumab the first drug approved to treat... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
Benlysta Proving Helpful for Lupus NephritisLupus is an autoimmune disease that can affect many parts of your body. Lupus can affect your:1 Your kidneys’ job is to maintain the right amount and types of fluids... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Grants Priority Review For Voclosporin For Lupus NephritisThe U.S. Food and Drug Administration (FDA) has granted Priority Review for voclosporin for the treatment of lupus nephritis.1Lupus nephritis is a severe and potentially life-threatening type of kidney disease... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Grants Fast Track Status To Telitacicept For LupusThe United States Food and Drug Administration (FDA) has granted Fast Track designation for a new lupus treatment option. The drug, called telitacicept or RC18, is an entirely new drug... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
ACR Guidelines for Infusions During COVID-19New guidelines from the American College of Rheumatology (ACR) recommend ways to manage infusion services during the COVID-19 pandemic. They also explain what doctors must consider when deciding to give... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
ACR Issues Guidelines To Ensure Access To HydroxychloroquineEditor’s Note: This article was first published on April 6, 2020. Further developments in what we know about the coronavirus are continuously emerging. Many people who need hydroxychloroquine (HCQ) are... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
Rheumatic Disease and the COVID-19 CoronavirusAs the number of cases of COVID-19 increases in the US and the world, people with rheumatic diseases are wondering if their immunosuppressants put them at greater risk of acquiring... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
